A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery

NCT ID: NCT02843594

Last Updated: 2016-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to evaluate the clinical outcomes of different cataract surgical techniques for lens fragmentation in subjects undergoing routine cataract surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LEEP Intervention C1

Cataract surgery with micro-interventional LEEP technology lens fragmentation (non-randomized cohort 1)

Group Type ACTIVE_COMPARATOR

LEEP intervention

Intervention Type PROCEDURE

Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation

LEEP Intervention C2

Cataract surgery with micro-interventional LEEP technology lens fragmentation (randomized cohort 2)

Group Type ACTIVE_COMPARATOR

LEEP intervention

Intervention Type PROCEDURE

Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation

Control Phaco C2

Cataract surgery with conventional phaco-assisted lens fragmentation (randomized cohort 2)

Group Type PLACEBO_COMPARATOR

Standard Phaco Control

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LEEP intervention

Low Energy Endosafe Phaco (LEEP) with micro-interventional lens fragmentation

Intervention Type PROCEDURE

Standard Phaco Control

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Able to understand study requirements, willing to follow study instructions and willing to return for required study follow-up visits as confirmed by provision of written informed consent.
2. Subjects with a visually significant cataract scheduled to undergo cataract surgery
3. Subjects \> 18 years of age
4. BCVA at baseline not better than 20/40
5. Grade 1+ cataracts

Exclusion Criteria

1. Subjects not able to complete the informed consent form
2. Subjects \< 18 years of age
3. Polar cataracts
4. Zonular instability
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iantech, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinica de Ojos Panama City

Panama City, , Panama

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Panama

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jennifer Gaines

Role: CONTACT

+1 (415) 295-4770

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ernesto Calvo, MD

Role: primary

(305) 898-0472

References

Explore related publications, articles, or registry entries linked to this study.

Ianchulev T, Chang DF, Koo E, MacDonald S, Calvo E, Tyson FT, Vasquez A, Ahmed IIK. Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomised controlled study. Br J Ophthalmol. 2019 Feb;103(2):176-180. doi: 10.1136/bjophthalmol-2017-311766. Epub 2018 Apr 18.

Reference Type DERIVED
PMID: 29669780 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LEEP103

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endothelial Cell Loss After Cataract Surgery
NCT00932191 TERMINATED PHASE2/PHASE3
IOP Changes Associated With SICS and Phako
NCT02642211 COMPLETED EARLY_PHASE1